Organovo Holdings Net Income 2011-2021 | ONVO

Organovo Holdings net income from 2011 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Organovo Holdings Annual Net Income
(Millions of US $)
2021 $-17
2020 $-19
2019 $-27
2018 $-35
2017 $-38
2016 $-39
2015 $-30
2014 $-26
2012 $-44
2011 $-4
2011 $-0
2011 $-0
2010 $
2010 $
Organovo Holdings Quarterly Net Income
(Millions of US $)
2021-06-30 $-3
2021-03-31 $-3
2020-12-31 $-3
2020-09-30 $-9
2020-06-30 $-3
2020-03-31 $-3
2019-12-31 $-3
2019-09-30 $-6
2019-06-30 $-6
2019-03-31 $-7
2018-12-31 $-6
2018-09-30 $-6
2018-06-30 $-7
2018-03-31 $-7
2017-12-31 $-8
2017-09-30 $-9
2017-06-30 $-10
2017-03-31 $-11
2016-12-31 $-10
2016-09-30 $-9
2016-06-30 $-9
2016-03-31 $-8
2015-12-31 $-10
2015-09-30 $-11
2015-06-30 $-8
2015-03-31 $-8
2014-12-31 $-7
2014-09-30 $-9
2014-06-30 $-6
2014-03-31 $-6
2013-12-31 $-5
2013-09-30 $-10
2013-06-30 $-4
2013-03-31
2012-12-31
2012-09-30 $38
2012-06-30 $-35
2012-03-31 $-37
2011-12-31
2011-09-30 $-1
2011-06-30
2011-03-31 $-1
2010-09-30 $-0
2010-06-30
2010-03-31 $-0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.052B $0.002B
Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.527B 7.92
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.184B 20.63
Biohaven Pharmaceutical Holding (BHVN) United States $8.967B 0.00
Emergent Biosolutions (EBS) United States $2.590B 6.25
Arcus Biosciences (RCUS) United States $2.362B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.929B 0.00
Myovant Sciences (MYOV) United Kingdom $1.832B 0.00
Zymeworks (ZYME) Canada $1.055B 0.00
Ambrx Biopharma (AMAM) United States $0.463B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.67